A287410 logo

Jeisys Medical Inc. Stock Price

KOSDAQ:A287410 Community·₩960.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A287410 Share Price Performance

₩0
0.00 (0.00%)
₩0
0.00 (0.00%)
Price ₩0

A287410 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with excellent balance sheet.

1 Risk
3 Rewards

Jeisys Medical Inc. Key Details

₩167.8b

Revenue

₩50.8b

Cost of Revenue

₩117.0b

Gross Profit

₩89.1b

Other Expenses

₩28.0b

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
375.50
69.73%
16.67%
60.6%
View Full Analysis

About A287410

Founded
2001
Employees
275
CEO
n/a
WebsiteView website
www.jeisys.com/2016

Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors. The company was founded in 2001 and is based in Seoul, South Korea. As of July 22, 2024, Jeisys Medical Inc. operates as a subsidiary of Syracuse Subco, Inc..

Recent A287410 News & Updates

Recent updates

No updates

Jeisys Medical Inc. Competitors